CLS Q2: Strong report that reinforces confidence in outlook - Redeye
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen

Aktieanalys

CLS Q2: Strong report that reinforces confidence in outlook - Redeye

{newsItem.title}

Redeye provides an update following CLS’s Q2 2025 report. We view the report as strong, providing confidence in our forecasts and the company’s objectives. Based on the results, we have made positive adjustments to our estimates, which lead to an updated fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1124336/cls-q2-strong-report-that-reinforces-confidence-in-outlook?utm_source=finwire&utm_medium=RSS

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt